NCT02500407 · Interventional trial
A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Overall registry status Completed
Phase 1 · Phase 2
Conditions Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin
Delaware Valley sites
- University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory